The aim of the Society of Endometriosis and Uterine Disorders (SEUD) is to provide an international scientific platform supporting better management of benign gynecological diseases and related uterine dysfunctions.
SEUD’s objective is to focus attention on a group of diseases that negatively affect womens’ health and fertility, including endometriosis, adenomyosis, uterine fibroids, polyps, heavy menstrual bleeding and uterine malformations.
SEUD aims to improve disease management and reduce the impact on women’s lives through focused debate on disease awareness, pathogenesis, risk factors, diagnosis and medical/surgical treatments.
SEUD also represents an international forum to promote education and training for a new generation of young experts with new perspectives based on translational research experience.
This forum will be supported by an annual meeting, the official Journal of Endometriosis and Pelvic Pain Disorders and a website facilitating a network of information and experts including gynecologists, biological scientists, bioengineers, and other stakeholders in women’s and reproductive health.
9th SEUD Annual Congress will be taking place in Abu Dhabi, the capital of the United Arab Emirates, from March 16th to 18th 2023.
In line with the tradition of the Society of Endometriosis and Uterine Disorders (SEUD), this annual congress will continue to bring more focus on the most recent updates and scientific debates within Endometriosis, Adenomyosis, Abnormal Uterine Bleeding and other benign uterine disorders.
Researchers, clinicians, surgeons and medical staff will gather from all of the world in the UAE to continue the odyssey towards unravelling the enigmas around the endometriotic disease, the multiple facets of adenomyosis, the staggering path to uterine fibroids genesis andconservative treatment and the ultimate social and clinical significance of abnormal uterine bleeding.